San Diego company testing artificial pancreas made from stem cells

San Diego's Viacyte is testing its artificial, lab-grown pancreas in three humans. The artificially derived pancreas cells are created using human stem cells and inserted into the subject through an incision in the back. In the hopes of treating diabetes, Medtronic ($MDT) and others are attempting to create a functional artificial pancreas using a mechanical approach. But Viacyte hopes the use of stem cells will enable it to create a truly artificial pancreas. Article

Suggested Articles

Akoya Biosciences raised $50 million to help boost its commercialization in research, drug development and clinical testing markets.

The dream of a comfortable, tabletop blood testing device, needing only a few drops taken from a finger and a handful of minutes, has now arrived.

Novartis is now teaming up with Amazon’s mammoth cloud computing division to overhaul its manufacturing, supply and business operations.